Correlation Between Nuvation Bio and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvation Bio and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvation Bio and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvation Bio and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Nuvation Bio and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvation Bio with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvation Bio and Acumen Pharmaceuticals.
Diversification Opportunities for Nuvation Bio and Acumen Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Nuvation and Acumen is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Nuvation Bio and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Nuvation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvation Bio are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Nuvation Bio i.e., Nuvation Bio and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvation Bio and Acumen Pharmaceuticals
Given the investment horizon of 90 days Nuvation Bio is expected to generate 0.79 times more return on investment than Acumen Pharmaceuticals. However, Nuvation Bio is 1.26 times less risky than Acumen Pharmaceuticals. It trades about 0.25 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 235.00 in Nuvation Bio on August 28, 2024 and sell it today you would earn a total of 54.00 from holding Nuvation Bio or generate 22.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvation Bio vs. Acumen Pharmaceuticals
Performance |
| Timeline |
| Nuvation Bio |
| Acumen Pharmaceuticals |
Nuvation Bio and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvation Bio and Acumen Pharmaceuticals
The main advantage of trading using opposite Nuvation Bio and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvation Bio position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.| Nuvation Bio vs. Eliem Therapeutics | Nuvation Bio vs. HCW Biologics | Nuvation Bio vs. Scpharmaceuticals | Nuvation Bio vs. Milestone Pharmaceuticals |
| Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |